Home » Topics » Regulatory

Regulatory
RSS

Velcade approved for relapsed mantle cell lymphoma

Dec. 12, 2006

Humira receives approval for expanded indication in psoriatic arthritis

Nov. 15, 2006

FDA approval for Polyphenon E Ointment

Nov. 2, 2006

Japanese approval for Sonazoid ultrasound contrast medium

Oct. 27, 2006

Noxafil approved for treatment of oropharyngeal candidiasis

Oct. 25, 2006

Seroquel approved for depressive episodes associated with bipolar disorder

Oct. 25, 2006

Remicade approved for maintenance therapy in ulcerative colitis

Oct. 20, 2006

Replagal approved for children from seven years with Fabry's disease in Europe

Oct. 20, 2006

Yallaferon approved in China for cervicitis

Oct. 19, 2006

Aricept approved for severe Alzheimer's disease

Oct. 17, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...